Differing Relations to Early Atherosclerosis between Vitamin C from Supplements vs. Food in the Los Angeles Atherosclerosis Study: A Prospective Cohort Study

Objective: To determine the relationship of vitamin c intake from supplements vs food on early atherosclerosis detected by carotid intima media thickness (IMT). Background: Oxidative stress and endothelial dysfunction play a critical role in the pathogenesis of atherosclerosis. Dietary vitamin C appears to have anti-oxidant properties and beneficial relations to endothelial function, yet vitamin C taken as a vitamin supplement does not appear to protect from cardiovascular events. The impact of vitamin c intake from supplements vs food on progression of atherosclerosis is unknown. Methods: We examined 3-year progression of carotid IMT in a randomly sampled cohort of 573 healthy women and men aged 40-60 years. Progression of carotid IMT was determined bilaterally with B-mode ultrasound at 3 examinations (1.5-year intervals). Intake of dietary vitamin C was measured by six, 24-hour recall interviews. Intake of vitamin C from vitamin supplements was measured by questionnaire in quartiles of supplement intake and no supplement. Vitamin C wasmeasured in plasma as ascorbic acid. Results: Carotid IMT progressed 10.0±16.5 μm/year (mean±SD) among all those with follow-up (n=500; 87%). For those who took vitamin C supplements, carotid IMT progression increased with dose (p-trend=0.0009). Among persons in the highest quartile (857-5000 mg/day) of vitamin C supplement intake compared to those not consuming any vitamin C supplements, carotid IMT progression increased three-fold (20.3±2.6 versus 7.6±1.8 μm/year (mean±SD); p<0.001). The adverse association of vitamin C supplement intake with carotid IMT was two-fold greater in the upper tertile of serum cholesterol compared to the lower two tertiles (p=0.01). In contrast to the adverse association of vitamin C supplements, vitamin C intake from food had a weak protective relationship on carotid IMT progression (reduced progression -5.0±1.9 μm/year; p=0.008). Conclusions: Vitamin C supplementation is associated with accelerated early atherosclerosis measured by carotid IMT compared to a protective association with vitamin C from food. Theadverse association of vitamin C supplementation may be greater in patients with higher serum cholesterol levels. The current results provide a potential mechanistic understanding for the observed differences between Vitamin C in supplements vs food in prior studies. Given these observations,vitamin C supplementation does not appear to be currently advisable for prevention or treatment of atherosclerosis.

[1]  T. Mäkikallio,et al.  Low β-carotene concentrations increase the risk of cardiovascular disease mortality among Finnish men with risk factors. , 2012, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[2]  R. Keogh,et al.  Vitamin C intake from diary recordings and risk of breast cancer in the UK Dietary Cohort Consortium , 2012, European Journal of Clinical Nutrition.

[3]  J. Manson,et al.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. , 2008, JAMA.

[4]  J. M. May,et al.  Inflammation in the vascular bed: importance of vitamin C. , 2008, Pharmacology & therapeutics.

[5]  J. Curb,et al.  Antioxidants in cardiovascular health and disease: key lessons from epidemiologic studies. , 2008, The American journal of cardiology.

[6]  J. Manson,et al.  Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. , 2008, JAMA.

[7]  Honglin Song,et al.  Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies , 2008, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[8]  H. Schellhorn,et al.  New developments and novel therapeutic perspectives for vitamin C. , 2007, The Journal of nutrition.

[9]  J. Manson,et al.  A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. , 2007, Archives of internal medicine.

[10]  D. Jacobs,et al.  Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. , 2007, The American journal of clinical nutrition.

[11]  Philippe Amouyel,et al.  Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. , 2006, The Journal of nutrition.

[12]  John Robbins,et al.  Calcium plus vitamin D supplementation and the risk of colorectal cancer. , 2006, The New England journal of medicine.

[13]  R. Hayes,et al.  Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. , 2006, Journal of the National Cancer Institute.

[14]  S. Yusuf,et al.  Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. , 2005, JAMA.

[15]  Roberto Pastor-Barriuso,et al.  Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality , 2005, Annals of Internal Medicine.

[16]  Alain Favier,et al.  The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. , 2004, Archives of internal medicine.

[17]  A. Folsom,et al.  Does supplemental vitamin C increase cardiovascular disease risk in women with diabetes? , 2004, The American journal of clinical nutrition.

[18]  MahmoudZureik,et al.  Effects of Long-Term Daily Low-Dose Supplementation With Antioxidant Vitamins and Minerals on Structure and Function of Large Arteries , 2004 .

[19]  P. Ducimetiere,et al.  Effects of Long-Term Daily Low-Dose Supplementation With Antioxidant Vitamins and Minerals on Structure and Function of Large Arteries , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[20]  J. Manson,et al.  Vitamin C and risk of coronary heart disease in women. , 2003, Journal of the American College of Cardiology.

[21]  J. Hsia,et al.  Effects of hormone replacement therapy and antioxidant vitamin supplements on coronary atherosclerosis in postmenopausal women: a randomized controlled trial. , 2002, JAMA.

[22]  W. W. Adams,et al.  Antioxidants in Photosynthesis and Human Nutrition , 2002, Science.

[23]  J. Manson,et al.  Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. , 2002, Archives of internal medicine.

[24]  R. Collins,et al.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[25]  Tw MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002, The Lancet.

[26]  A. Coats MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[27]  E. Bolson,et al.  Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. , 2001, The New England journal of medicine.

[28]  L. Kuller A time to stop prescribing antioxidant vitamins to prevent and treat heart disease? , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[29]  B. G. Brown,et al.  Antioxidant Supplements Block the Response of HDL to Simvastatin-Niacin Therapy in Patients With Coronary Artery Disease and Low HDL , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[30]  J. Dwyer,et al.  Oxygenated Carotenoid Lutein and Progression of Early Atherosclerosis: The Los Angeles Atherosclerosis Study , 2001, Circulation.

[31]  M. D. De Buyzere,et al.  Serum Vitamin C Concentration Is Low in Peripheral Arterial Disease and Is Associated With Inflammation and Severity of Atherosclerosis , 2001, Circulation.

[32]  S. Yusuf,et al.  Effects of Ramipril and Vitamin E on Atherosclerosis: The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE) , 2001, Circulation.

[33]  T. Lakka,et al.  Antioxidant Supplementation in Atherosclerosis Prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3‐year progression of carotid atherosclerosis , 2000, Journal of internal medicine.

[34]  M. Boaz,et al.  Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial , 2000, The Lancet.

[35]  C. A. Johnson,et al.  Blood pressure, LDL cholesterol, and intima-media thickness: a test of the "response to injury" hypothesis of atherosclerosis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[36]  L. Labree,et al.  Correlations between measures of atherosclerosis change using carotid ultrasonography and coronary angiography. , 2000, Atherosclerosis.

[37]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[38]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[39]  J. Fleg,et al.  Increased carotid artery intimal-medial thickness in asymptomatic older subjects with exercise-induced myocardial ischemia. , 1998, Circulation.

[40]  R H Selzer,et al.  Automated intima-media thickness: the Los Angeles Atherosclerosis Study. , 1998, Ultrasound in medicine & biology.

[41]  R H Selzer,et al.  The Role of Carotid Arterial Intima-Media Thickness in Predicting Clinical Coronary Events , 1998, Annals of Internal Medicine.

[42]  T. Cole,et al.  Plasma total homocysteine in a representative sample of 972 British men and women aged 65 and over , 1997, European Journal of Clinical Nutrition.

[43]  J. Scott Bioavailability of vitamin B12. , 1997, European journal of clinical nutrition.

[44]  C. Bates Bioavailability of vitamin C. , 1997, European journal of clinical nutrition.

[45]  Paul Knekt,et al.  Flavonoid intake and coronary mortality in Finland: a cohort study , 1996, BMJ.

[46]  D Kromhout,et al.  Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. , 1995, Archives of internal medicine.

[47]  D. Albanes,et al.  The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. , 1994, The New England journal of medicine.

[48]  J. Gregory Ascorbic acid bioavailability in foods and supplements. , 2009, Nutrition reviews.

[49]  M. Gail,et al.  Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. , 1993, Journal of the National Cancer Institute.

[50]  P. Taylor,et al.  The bioavailability to humans of ascorbic acid from oranges, orange juice and cooked broccoli is similar to that of synthetic ascorbic acid. , 1993, The Journal of nutrition.

[51]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[52]  J. Manson,et al.  Dietary Antioxidants and Cardiovascular Disease , 1992, Annals of the New York Academy of Sciences.

[53]  R. Hoffmann,et al.  Ascorbic acid requirements for smokers: analysis of a population survey. , 1991, The American journal of clinical nutrition.

[54]  R. Ziegler,et al.  Ascorbic and dehydroascorbic acids measured in plasma preserved with dithiothreitol or metaphosphoric acid. , 1990, Clinical chemistry.

[55]  D Feskanich,et al.  Computerized collection and analysis of dietary intake information. , 1989, Computer methods and programs in biomedicine.

[56]  S. Omaye,et al.  An internal standard method for the unattended high-performance liquid chromatographic analysis of ascorbic acid in blood components. , 1987, Analytical biochemistry.

[57]  J. Dwyer,et al.  Statistical Models for the Social and Behavioral Sciences , 1983 .